Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)
China
· Delayed Price · Currency is CNY 24.15
-0.41 (-1.67%)
Mar 9, 2026, 3:04 PM CST
SHE:300357 Revenue
Zhejiang Wolwo Bio-Pharmaceutical had revenue of 369.12M CNY in the quarter ending September 30, 2025, with 22.64% growth. This brings the company's revenue in the last twelve months to 1.05B, up 15.90% year-over-year. In the year 2024, Zhejiang Wolwo Bio-Pharmaceutical had annual revenue of 925.39M with 9.10% growth.
Revenue (ttm)
1.05B
Revenue Growth
+15.90%
P/S Ratio
12.06
Revenue / Employee
624.49K
Employees
1,679
Market Cap
12.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 925.39M | 77.20M | 9.10% |
| Dec 31, 2023 | 848.19M | -47.83M | -5.34% |
| Jan 1, 2023 | 896.02M | 88.32M | 10.94% |
| Dec 31, 2021 | 807.69M | 171.48M | 26.95% |
| Dec 31, 2020 | 636.21M | -3.14M | -0.49% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Yifan Pharmaceutical | 5.22B |
| Zhejiang Jolly Pharmaceutical Co.,LTD | 2.81B |
| Aurora Optoelectronics | 422.81M |
| GuangYuYuan Chinese Herbal Medicine | 1.39B |
| Shanghai InnoStar Bio-tech | 811.33M |
| Nanjing Pharmaceutical Group Company | 53.89B |
| Zhejiang Int'l Group | 33.54B |
| Hunan Jingfeng Pharmaceutical | 393.19M |